关注
Andrew Gasparrini
Andrew Gasparrini
Empress Therapeutics
在 empresstx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Next-generation approaches to understand and combat the antibiotic resistome
TS Crofts, AJ Gasparrini, G Dantas
Nature Reviews Microbiology 15 (7), 422-434, 2017
5642017
Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome
AJ Gasparrini, B Wang, X Sun, EA Kennedy, A Hernandez-Leyva, ...
Nature microbiology 4 (12), 2285-2297, 2019
2502019
Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance
AJ Gasparrini, JL Markley, H Kumar, B Wang, L Fang, S Irum, CT Symister, ...
Communications biology 3 (1), 241, 2020
1372020
Antibiotic perturbation of the preterm infant gut microbiome and resistome
AJ Gasparrini, TS Crofts, MK Gibson, PI Tarr, BB Warner, G Dantas
Gut microbes 7 (5), 443-449, 2016
1292016
Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut
N Crook, A Ferreiro, AJ Gasparrini, MW Pesesky, MK Gibson, B Wang, ...
Cell host & microbe 25 (4), 499-512. e8, 2019
1222019
Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes
J Park, AJ Gasparrini, MR Reck, CT Symister, JL Elliott, JP Vogel, ...
Nature chemical biology 13 (7), 730-736, 2017
1162017
Multiscale evolutionary dynamics of host-associated microbiomes
A Ferreiro, N Crook, AJ Gasparrini, G Dantas
Cell 172 (6), 1216-1227, 2018
1122018
Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes
B Adu‐Oppong, AJ Gasparrini, G Dantas
Annals of the New York Academy of Sciences 1388 (1), 42-58, 2017
502017
Maternal activation of the EGFR prevents translocation of gut-residing pathogenic Escherichia coli in a model of late-onset neonatal sepsis
KA Knoop, PE Coughlin, AN Floyd, IM Ndao, C Hall-Moore, N Shaikh, ...
Proceedings of the National Academy of Sciences 117 (14), 7941-7949, 2020
472020
Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes
JL Markley, L Fang, AJ Gasparrini, CT Symister, H Kumar, NH Tolia, ...
ACS infectious diseases 5 (4), 618-633, 2019
322019
Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol 4: 2285–2297
AJ Gasparrini, B Wang, X Sun, EA Kennedy, A Hernandez-Leyva, ...
182019
Physiologically acceptable compositions containing microorganisms or microbial products
DG Cole, J Park, SY Yang, AJ Gasparrini
US Patent App. 18/009,395, 2023
2023
Inhibition and diagnostics of emerging tetracycline resistance enzymes
N Tolia, G Dantas, T Wencewicz, J Park, A Gasparrini, K Forsberg, ...
US Patent 10,273,468, 2019
2019
Semisynthetic analogues of anhydrotetracycline as potential inhibitors of tetracycline destructase enzymes
J Markley, L Fang, A Gasparrini, C Symister, H Kumar, G Dantas, N Tolia, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018
2018
Mechanistic characterization of resistome and microbiome dynamics across diverse microbial habitats
AJ Gasparrini
Washington University in St. Louis, 2018
2018
Identifying Potential Drivers of Differential DNA Methylation Patterns in Breast Cancer Cells
A Fennoy, J Fong, J Andrews, A Gasparrini, J Edwards
The FASEB Journal 29, LB143, 2015
2015
Metagenomic signatures of early life hospitalization and antibiotic treatment in the infant gut microbiota and resistome persist long after discharge
AJ Gasparrini, B Wang, X Sun, EA Kennedy, A Hernandez-Leyva, ...
系统目前无法执行此操作,请稍后再试。
文章 1–17